Joshua Malo is a Respiratory physician affiliated with University of Arizona. OpenAlex indexes 80 publications with 1,297 citations (h-index 18).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1501 N Campbell Ave
Dept Of Medicine
Tucson, AZ 857240001
Telephone
520-694-4000Registry record last updated 19 Sept 2016.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Paragonix Technologies, Inc.Program year20243 payments
- La Jolla Pharmaceutical CompanyProgram year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
43.7%Azole Antifungal13.7%Fluconazole58%Posaconazole42%Part D<11 patientsMacrolide Antimicrobial11.8%Azithromycin100%Part D≥21 patients+ 3 more classes in this area
Metabolism & gastrointestinal
18.5%Corticosteroid14.8%Prednisone100%Part D≥21 patientsProton pump inhibitor3.6%Pantoprazole Sodium100%Part D<11 patientsCancer & immunology
13.4%Calcineurin inhibitor9%Tacrolimus100%Part D<11 patientsKinase inhibitor4.5%Sirolimus100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Sex hormones influence ORMDL3 expression: Implications for sex-associated asthma phenotype
Journal of Allergy and Clinical Immunology
2025 - Lung NR3C1+ and CXCR6high T cells distinguish immunopathogenesis of human emphysema
Communications Biology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Joseph Alpert, MD
University of Arizona
Karl Kern, MD
University of Arizona
Peter Reaven, MD
University of Arizona
Alison Stopeck, MD
University of Arizona
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”